Gofen & Glossberg LLC Nymox Pharmaceutical Corp Transaction History

Gofen & Glossberg LLC

  • $3.89 Billion
  • Q4 2022

A detailed history of Gofen & Glossberg LLC transactions in Nymox Pharmaceutical Corp stock. As of the latest transaction made, Gofen & Glossberg LLC holds 25,000 shares of NYMX stock, worth $11,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Previous 50,000 50.0%
Holding current value
$11,750
Previous $21,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023
SELL
$0.28 - $0.74 $7,000 - $18,500
-25,000 Reduced 50.0%
25,000 $7,000
Q3 2022

Oct 13, 2022
BUY
$0.22 - $0.61 $5,500 - $15,250
25,000 Added 100.0%
50,000 $21,000
Q2 2017

Aug 16, 2017
BUY
N/A
25,000
25,000 $110,000

Others Institutions Holding NYMX

# of Institutions
5
Shares Held
74.9K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Gofen & Glossberg LLC Portfolio

Follow Gofen & Glossberg LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gofen & Glossberg LLC , based on Form 13F filings with the SEC.

News

Stay updated on Gofen & Glossberg LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email